Enveda
- Health & Biotech
- Boulder, Colorado, US
- Founded 2019
- Private
- enveda.com
AI-enabled drug discovery company that mines chemistry from natural sources to develop small-molecule medicines.
$461MEquity raised in 2025–20262025 $150M · 2026 $311M · 2 equity rounds
$516MEquity raised, all time3 equity rounds sourced so far
$2BLatest valuationpost-money, as reported
Rounds over time log-scaled amounts
Funding history 3 rounds · 5 sources · newest first
Earlier rounds not yet sourced. Enveda was founded in 2019 and raised before 14 Jun 2024; only the rounds below are sourced so far, so its all-time equity total understates its history.
- Series EAmount$311MPost-money$2B✓ Confirmed
- Series DAmount$150MPost-money—✓ Confirmed
- Series B2Amount$55MPost-money—◔ Reported
- Earlier rounds not yet sourced
Investors 18
- Premji Invest2
- Catalio Capital Management1
- Exor2
- FPV2
- Kinnevik2
- Level Ventures2
- Baillie Gifford
- Dimension
- Henry Kravis
- IA Ventures
- ICONIQ
- Jazz Venture Partners
- Lux Capital
- Microsoft
- Peakline Partners
- Socium Ventures
- The Nature Conservancy
- True Ventures
Highlighted investors led at least one equity round; the number is equity rounds taken part in.
Related companies shared investors
AnthropicAI Labs · $113B in 2025–2026Shared: Microsoft, Baillie Gifford +1HadrianDefense · $1.8B in 2025–2026Shared: Baillie Gifford, Lux CapitalDatabricksEnterprise · $10B in 2025–2026Shared: Premji Invest, ICONIQRampFintech · $3.6B in 2025–2026Shared: Lux Capital, ICONIQQuinceConsumer · $700M in 2025–2026Shared: Baillie Gifford, ICONIQRunwayAI Apps · $623M in 2025–2026Shared: Premji Invest, Baillie Gifford
Figures in USD at the time of each round. See the methodology for how rounds are sourced and verified. Enveda and its logo are trademarks of their owners, used here for identification only.
